Oral tolerance and regulation of mucosal immunity

Cellular and Molecular Life Sciences

Volumn 62, Issue 12, 2005, Pages 1322-1332

  Dubois, B ^a   Goubier, A ^a   Joubert, G ^a   Kaiserlian, D ^a  

^a INSERM   (France)

Author keywords

Commensal flora; Dendritic cells; Intestine; Regulatory CD4+ T cells; Tolerance

Indexed keywords

ANTIGEN; CD11 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE CCL20; CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LYMPHOTOXIN BETA RECEPTOR IMMUNOGLOBULIN; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR 1 IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BIFIDOBACTERIUM LONGUM INFANTIS; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DRUG MEGADOSE; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSTIMULATION; INTESTINE; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INFECTION; INTESTINE MUCOSA; LACTOBACILLUS; LACTOBACILLUS PARACASEI; LOW DRUG DOSE; MUCOSAL IMMUNITY; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS); CELLULAR ORGANISMS;

EID: 20744459116     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5036-0     Document Type: Review

References (144)

1. Mowat A. M. (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341
2. Garside P., Mowat A. M. and Khoruts A. (1999) Oral tolerance in disease. Gut 44: 137-142
3. Richman L. K., Graeff A. S., Yarchoan R. and Strober W. (1981) Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding. J. Immunol. 126: 2079-2083
4. Chen Y., Kuchroo V. K., Inobe J., Hafler D. A. and Weiner H. L. (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240
5. Fujihashi K., Dohi T., Rennert P. D., Yamamoto M., Koga T., Kiyono H. et al. (2001) Peyer's patches are required for oral tolerance to proteins. Proc. Natl. Acad. Sci. USA 98: 3310-3315
6. Spahn T. W., Fontana A., Faria A. M., Slavin A. J., Engster H. P., Zhang X. et al. (2001) Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur. J. Immunol. 31: 1278-1287
7. Alpan O., Rudomen G. and Matzinger P. (2001) The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J. Immunol. 166: 4843-4852
8. Enders G., Gottwald T. and Brendel W. (1986) Induction of oral tolerance in rats without Peyer's patches. Immunology 58: 311-314
9. Spahn T. W., Weiner H. L., Rennert P. D., Lugering N., Fontana A., Domschke W et al. (2002) Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur. J. Immunol. 32: 1109-1113
10. Kunkel D., Kirchhoff D., Nishikawa S., Radbruch A. and Scheffold A. (2003) Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice. Eur. J. Immunol. 33: 1292-1301
11. Kaiserlian D. (1999) Epithelial cells in antigen. Sampling and presentation in mucosal tissues. Curr. Top. Microbiol. Immunol. 236: 55-78
12. Hershberg R. M., Cho D. H., Youakim A., Bradley M. B., Lee J. S., Framson P. E. et al. (1998) Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J. Clin. Invest. 102: 792-803
13. Zimmer K. P., Buning J., Weber P., Kaiserlian D. and Strobel S. (2000) Modulation of antigen trafficking to MHC class II-positive late endosomes of enterocytes. Gastroenterology 118: 128-137
14. Hershberg R. M. and Mayer L. F. (2000) Antigen processing and presentation by intestinal epithelial cells polarity and complexity. Immunol. Today 21: 123-128
15. Vidai K., Samarut C., Magaud J. P., Revillard J. P. and Kaiserlian D. (1993) Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. J. Immunol. 151: 4642-4650
16. Allez M., Brimnes J., Dotan I. and Mayer L. (2002) Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 123: 1516-1526
17. Cruickshank S. M., McVay L. D., Baumgart D. C., Felsburg P. J. and Carding S. R. (2004) Colonic epithelial cell-mediated suppression of CD4 T cell activation. Gut 53: 678-684
18. Galliaerde V., Desvignes C., Peyron E. and Kaiserlian D. (1995) Oral tolerance to haptens: intestinal epithelial cells from 2.4-dinitrochlorobenzene- fed mice inhibit hapten-specific T cell activation in vitro. Eur. J. Immunol. 25: 1385-1390
19. Huang F. P,. Platt N., Wykes M., Major J. R., Powell T. J., Jenkins C. D. et al. (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191: 435-443
20. Karlsson M., Lundin S., Dahlgren U., Kahu H., Pettersson I. and E. Telemo. (2001) 'Tolerosomes' are produced by intestinal epithelial cells. Eur. J. Immunol. 31: 2892-2900
21. Sierro F., Dubois B., Coste A., Kaiserlian D., Kraehenbuhl J. P. and Sirard J. C. (2001) Flagellin stimulation of intestinal epithelial cells triggers CCE20- mediated migration of dendritic cells. Proc. Natl. Acad. Sci. USA 98: 13722-13727
22. Neish A. S., Gewirtz A. T., Zeng H., Young A. N., Hobert M. E., Karmali V. et al. (2000) Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289: 1560-1563
23. Kelly D., Campbell J. I., King T. P., Grant G., Jansson E. A., Courts A. G. et al. (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and Re1A. Nat. Immunol. 5: 104-112
24. Gonnella P. A., Chen Y., Inobe J., Komagata Y., Quartulli M. and Weiner H. L. (1998) In situ immune response in gut-associated lymphoid tissue (GAET) following oral antigen in TCR-transgenic mice. J. Immunol. 160: 4708-4718
25. Kalinski P., Hilkens C. M., Snijders A., Snijdewint F. G. and Kapsenberg M. L. (1997) IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159: 28-35
26. Maric I., Holt P. G., Perdue M. H. and Bienenstock J. (1996) Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J. Immunol. 156: 1408-1414
27. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R. et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367
28. Liu L. M. and MacPherson G. G. (1993) Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177: 1299-1307
29. Peng H. J., Turner M. W. and Strobel S. (1990) The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 81: 510-515
30. Williamson E., O'Malley J. M. and Viney J. L. ( 1999) Visualizing the T-cell response elicited by oral administration of soluble protein antigen. Immunology 97: 565-572
31. Sun J. Dirden-Kramer B., Ito K., Ernst P. B. and Van Houten N. (1999) Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 162: 5868-5875
32. + T cells. J. Immunol. 164: 2890-2896
33. Benson J. M., Campbell K. A., Guan Z., Gienapp I. E., Stuckman S. S., Forsthuber T. et al. (2000) T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 106: 1031-1038.
34. Gutgemann I., Fahrer A. M., Altman J. D., Davis M. M. and Chien Y. H. (1998) Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 8: 667-673
35. Kobets N., Kennedy K. and Garside P. (2003) An investigation of the distribution of antigen fed in tolerogenic or immunogenic forms. Immunol. Lett. 88: 147-155
36. Smith K. M., Davidson J. M. and P. Garside (2002) T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen, although tolerized T cells display a defect in cell division. Immunology 106: 144-158
37. Ju C. and Pohl L. R. (2001) Immunohistochemical detection of protein adducts of 2,4-dinitrochlorobenzene in antigen-presenting cells and lymphocytes after oral administration to mice: lack of a role of Kupffer cells in oral tolerance. Chem. Res. Toxicol. 14: 1209-1217
38. Hanson D. G. and Miller S. D. (1982) Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells. J. Immunol. 128: 2378-2381
39. Friedman A. and Weiner H. L. (1994) Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. 91: 6688-6692
40. Chen Y., Inobe I. Marks R., Gonnella P., Kuchroo V. K. and Weiner H. L. (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376: 177-180
41. Ueda Y., Hachimura S., Somaya T., Hisatsune T. and Kaminogawa S. (2001) Apoptosis of antigen-specific T cells induced by oral administration of antigen: comparison of intestinal and non-intestinal immune organs. Biosci. Biotechnol. Biochem. 65: 1170-1174
42. Kaji T., Hachimura S., Ise W. and Kaminogawa S. (2003) Proteome analysis reveals caspase activation in hyporesponsive CD4 T lymphocytes induced in vivo by the oral administration of antigen. J. Biol. Chem. 278: 27836-27843
43. Whitacre C. C., Gienapp I. E., Orosz C. G. and Bitar D. M. (1991) Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147: 2155-2163
44. Melamed D. and A. Friedman (1993) Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23: 935-942
45. Melamed D. and A. Friedman (1994) In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Eur. J. Immunol. 24: 1974-1981
46. Van Houten N. and Blake S. F. (1996) Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 157: 1337-1341
47. Lombardi G., Sidhu S., Batchelor R. and Lechler R. (1994) Anergic T cells as suppressor cells in vitro. Science 264: 1587-1589
48. Lider O., Santos L. M., Lee C. S., Higgins P. J. and Weiner H. L. (1989) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J. Immunol. 142: 748-752
49. + cells suppress experimental autoimmune uveitis. Eur. J. Immunol. 26: 2140-2148
50. + T cells are required for the induction of oral tolerance. Int. Immunol. 7: 501-504
51. + cells on the induction and maintenance of oral tolerance. Cell. Immunol. 163: 19-29
52. + T cell-depleted mice. Eur. J. Immunol. 26: 1756-1761
53. + T cells. J. Immunol. 164: 2515-2522
54. Miller A., Lider O., Roberts A. B., Sporn M. B. and Weiner H. L. (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89: 421-425
55. Santos L. M., al-Sabbagh A., Londono A. and Weiner H. L. (1994) Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell. Immunol. 157: 439-447
56. Weiner H. L. (2001) Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3: 947-954
57. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400
58. O'Garra A. and Vieira P. (2003) Twenty-first century Foxp3. Nat. Immunol. 4: 304-306
59. +) regulatory T cells by oral antigen administration. J. Immunol. 167: 4245-4253
60. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167: 188-195
61. + mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur. J. Immunol. 33: 2801-2810
62. +) T cell-mediated contact hypersensitivity. J. Exp. Med. 189: 779-786
63. + T cells mediating skin inflammation. Blood 102: 3295-3301
64. + regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 199: 1679-1688
65. +) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194: 629-644
66. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742
67. +) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222
68. + regulatory T cells. J. Immunol. 172: 5986-5993
69. Akbari O., Freeman G. J., Meyer E. H., Greenfield E. A., Chang T. T., Sharpe A. H. et al. (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032
70. Cong Y., Weaver C. T., Lazenby A. and Elson C. O. (2002) Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169: 6112-6119
71. Daynes R. A., Araneo B. A., Dowell T. A., Huang K. and D. Dudley (1990) Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J. Exp. Med. 171: 979-996
72. Eaton A. D., Xu D. and Garside P. (2003) Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology 108: 196-203
73. Williamson E., Westrich G. M. and Viney J. L. (1999) Modulating dendritic cells to optimize mucosal immunization protocols. J. Immunol. 163: 3668-3675
74. Kitani A., Fuss I. J., Nakamura K., Schwartz O. M., Usui T. and Strober W. (2000) Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-betal plasmid: TGF-beta 1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J. Exp. Med. 192: 41-52
75. Slavin A. J., Maron R. and Weiner H. L. (2001) Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int. Immunol. 13: 825-833
76. Kellermann S. A. and McEvoyv L. M. (2001) The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J. Immunol. 167: 682-690
77. Xu-Amano J., Aicher W. K., Taguchi T., Kiyono H. and McGhee J. R. (1992) Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 4: 433-445
78. Jump R. L. and Levine A. D. (2002) Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J. Immunol. 168: 6113-6119
79. +) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99: 2468-2476
80. + cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J. Immunol. 171: 2270-2278
81. + T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J. Immunol. 160: 5719-5728
82. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886
83. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153
84. - T cells to acquire regulatory cell function. Blood 101: 5076-5083
85. Kiyono H., McGhee J. R., Wannemuehler M. J. and Michalek S. M. (1982) Lack of oral tolerance in C3H/HeJ mice. J. Exp. Med. 155: 605-610
86. Wannemuehler M. J., Kiyono H., Babb J. L., Michalek S. M. and McGhee J. R. (1982) Lipopolysaccharide (LPS) regulation of the immune response: LPS converts germfree mice to sensitivity to oral tolerance induction. J. Immunol. 129: 959-965
87. Michalek S. M., Kiyono H., Wannemuehler M. J., Mosteller L. M. and McGhee J. R. (1982) Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J. Immunol. 128: 1992-1998
88. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C. and Koga Y. (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159: 1739-1745
89. Moreau M. C. and Corthier G. (1988) Effect of the gastro-intestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice. Infect. Immun. 56: 2766-2768
90. Khoury S. J., Lider O., al-Sabbagli A. and Weiner H. L. (1990) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell. Immunol. 131: 302-310
91. Beatty W. L. and Sansonetti P. J. (1997) Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes. Infect. Immun. 65: 4395-4404
92. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K. M., Brigidi P. et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209
93. +) T cell-mediated skin inflammation. Eur J Immunol 34: 2520-2528
94. Sakaguchi S. (2003) Control of immune responses by naturally arising CD4+ regulatory T cells that express toll-like receptors. J. Exp. Med. 197: 397-401
95. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M. and Demengeot J. (2003) Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411
96. Netea M. G., Sutmuller R., Hermann C., Van der Graaf C. A., Van der Meer J. W., van Krieken J. H. et al. (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712-3718
97. Christensen H. R., Frokiaer H. and Pestka J. J. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168: 171-178
98. +) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin. Diagn. Lab. Immunol. 8: 695-701
99. Asseman C., Mauze S., Leach M. W., Coffmanv and Powrie F. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004
100. +) T cells. J Autoimmun 16: 115-123
101. + regulatory T cells cure murine colitis: the role of IL-10, TGF-beta and CTLA4. J. Immunol. 171: 5012-5017
102. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197: 111-119
103. Aroeira L. S., Cardillo F., De Albuquerque D. A., Vaz N. M. and Mengel J. (1995) Anti-IL-10 treatment does not block either the induction or the maintenance of orally induced tolerance to OVA. Scand. J. Immunol. 41: 319-323
104. Barone K. S., Tolarova D. D., Ormsby I., Doetschman T. and Michael J. G. (1998) Induction of oral tolerance in TGF-beta 1 null mice. J. Immunol. 161: 154-160
105. Rizzo L. V., Morawetz R. A., Miller-Rivero N. E., Choi R., Wiggert B., Chan C. C. et al. (1999) IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 162: 2613-2622
106. Fowler S. and Powrie F. (2002) CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur. J. Immunol. 32: 2997-3006
107. Fuss I. J., Boirivant M., Lacy B. and Strober W. (2002) The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J. Immunol. 168: 900-908
108. Cottrez F. and Groux H. (2001) Regulation of TGF-beta response during T cell activation is modulated by IL-10. J. Immunol. 167: 773-778
109. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T. and Strober W. (2003) Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 198: 1179-1188
110. +) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196: 247-253
111. +) T helper cells. J. Exp. Med. 196: 255-260
112. Roelofs-Haarhuis K., Wu X., Nowak M., Fang M., Artik S. and Gleichmann E. (2003) Infectious nickel tolerance: a reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization. J. Immunol. 171: 2863-2872
113. Homann D., Dyrberg T., Petersen J., Oldstone M. B. and von Herrath M. G. (1999) Insulin in oral immune 'tolerance': a one-amino acid change in the B chain makes the difference. J. Immunol. 163: 1833-1838
114. Alpan O., Bachelder E., Isil E., Arnheiter H. and Matzinger P. (2004) 'Educated' dendritic cells act as messengers from memory to naive T helper cells. Nat. Immunol. 5: 615-622
115. Viney J. L., Mowat A. M., O'Malley J. M., Williamson E. and Fanger N. A. (1998) Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160: 5815-5825
116. Akbari O., DeKruyff R. H. and Umetsu D. T. (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731
117. Kelsall B. L. and Strober W. (1996) Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J. Exp. Med. 183: 237-247
118. +, and double-negative Peyer's patch dendritic cells. J. Immunol. 166: 4884-4890
119. Iwasaki A. and Kelsall B. L. (2000) Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J. Exp. Med. 191: 1381-1394
120. Asselin-Paturel C., Brizard G., Pin J. J., Briere F. and Trinchieri G. (2003) Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171: 6466-6477
121. + DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 108: 481-492
122. Iwasaki A. and Kelsall B. L. (1999) Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190: 229-239
123. Williamson E., Bilsborough J. M. and Viney J. L. (2002) Regulation of mucosal dendritic cell function by receptor activator of NF-κB (RANK)/RANK ligand interactions: impact on tolerance induction. J. Immunol. 169: 3606-3612
124. Wakkach A., Fournier N., Brun V., Breittmayer J. P., Cottrez F. and Groux H. (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617
125. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C. et al. (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2: 1144-1150
126. Rissoan M. C., Soumelis V., Kadowaki N., Grouard G., Briere F. de Waal R., Malefyt et al. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-1186
127. Boonstra A., Asselin-Paturel C., Gilliet M., Crain C., Trinchieri G., Liu Y. J. et al. (2003) Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197: 101-109
128. Gilliet M. and Liu Y. J. (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195: 695-704
129. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100: 383-390
130. +) T cell anergy by peripheral blood DC2 precursors. Eur. J. Immunol. 31: 2547-2557
131. Mellor A. L., Keskin D. B., Johnson T., Chandler P. and Munn D. H. (2002) Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J. Immunol. 168: 3771-3776
132. +) dendritic cells. Int. Immunol. 14: 65-68
133. Grohmann U., Fallarino F. and Puccetti P. (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24: 242-248
134. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A. et al. (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9: 1069-1077
135. Munn D. H., Sharma M. D., Lee J. R., Jhaver K. G., Johnson T. S., Keskin D. B. et al. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870
136. Crispe I. N. (2003) Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3: 51-62
137. Cantor H. M. and Dumont A. E. (1967) Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215: 744-745
138. Yang R., Liu Q., Grosfeld J. L. and Pescovitz M. D. (1994) Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction. J. Pediatr. Surg. 29: 1145-1148
139. + T cells expressing CD95 ligand and secreting IE-4 in the liver. J. Immunol. 168: 2188-2199
140. + Th2 cells via apoptosis. Hepatology 38: 403-412
141. Pillarisetty V. G., Shah A. B., Miller G., Bleier J. I. and De-Matteo R. P. (2004) Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 172: 1009-1017
142. Lian Z. X., Okada T., He X. S., Kita H., Liu Y. J., Ansari A. A. et al. (2003) Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J. Immunol. 170: 2323-2330
143. Homann D., Jahreis A., Wolfe T., Hughes A., Coon B., van Stipdonk M. J. et al. (2002) CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16: 403-415
144. Mayer L. and Shao L. (2004) Therapeutic potential of oral tolerance. Nat. Rev. Immunol. 4: 407-419